Truist Financial Corp Sells 3,033 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Truist Financial Corp cut its position in shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 15.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,562 shares of the health services provider’s stock after selling 3,033 shares during the period. Truist Financial Corp’s holdings in Teladoc Health were worth $420,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Activest Wealth Management increased its position in shares of Teladoc Health by 270.5% during the third quarter. Activest Wealth Management now owns 678 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 495 shares during the period. SeaCrest Wealth Management LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at $28,000. Bank Julius Baer & Co. Ltd Zurich boosted its stake in Teladoc Health by 962.0% in the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,062 shares of the health services provider’s stock valued at $35,000 after buying an additional 962 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in Teladoc Health by 23.3% in the 2nd quarter. Quadrant Capital Group LLC now owns 1,385 shares of the health services provider’s stock valued at $46,000 after buying an additional 262 shares in the last quarter. Finally, Ellevest Inc. boosted its stake in Teladoc Health by 65.2% in the 2nd quarter. Ellevest Inc. now owns 1,437 shares of the health services provider’s stock valued at $48,000 after buying an additional 567 shares in the last quarter. 84.14% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Teladoc Health news, insider Arnnon Geshuri sold 2,398 shares of the stock in a transaction dated Monday, November 28th. The stock was sold at an average price of $27.35, for a total value of $65,585.30. Following the completion of the sale, the insider now directly owns 74,317 shares in the company, valued at $2,032,569.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Arnnon Geshuri sold 2,398 shares of the company’s stock in a transaction dated Monday, November 28th. The stock was sold at an average price of $27.35, for a total transaction of $65,585.30. Following the completion of the transaction, the insider now directly owns 74,317 shares of the company’s stock, valued at $2,032,569.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction dated Tuesday, January 17th. The stock was sold at an average price of $26.80, for a total value of $26,800.00. Following the transaction, the senior vice president now directly owns 21,408 shares of the company’s stock, valued at $573,734.40. The disclosure for this sale can be found here. Insiders sold 3,925 shares of company stock worth $107,958 over the last ninety days. 1.55% of the stock is currently owned by corporate insiders.

Teladoc Health Trading Down 1.7 %

NYSE TDOC opened at $27.20 on Wednesday. The stock has a 50-day simple moving average of $26.24 and a 200 day simple moving average of $29.98. The company has a market capitalization of $4.40 billion, a PE ratio of -0.44 and a beta of 0.98. The company has a current ratio of 3.13, a quick ratio of 2.99 and a debt-to-equity ratio of 0.25. Teladoc Health, Inc. has a 12 month low of $21.60 and a 12 month high of $80.83.

Teladoc Health (NYSE:TDOCGet Rating) last announced its quarterly earnings results on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.14. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. The company had revenue of $611.40 million during the quarter, compared to the consensus estimate of $609.45 million. Research analysts forecast that Teladoc Health, Inc. will post -1.4 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on TDOC. Barclays decreased their price target on Teladoc Health from $32.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Wednesday, January 18th. Royal Bank of Canada decreased their price target on Teladoc Health from $53.00 to $35.00 in a research note on Wednesday, September 28th. Deutsche Bank Aktiengesellschaft decreased their price target on Teladoc Health from $34.00 to $31.00 and set a “hold” rating on the stock in a research note on Tuesday, September 27th. Citigroup reduced their price objective on Teladoc Health from $36.00 to $33.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 13th. Finally, Cowen reduced their price objective on Teladoc Health to $30.00 in a research note on Thursday, October 27th. One investment analyst has rated the stock with a sell rating, twenty-two have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $47.79.

Teladoc Health Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Recommended Stories

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.